- Report
- November 2022
Paraguay
From €1650EUR$1,850USD£1,431GBP
- Report
- November 2022
Panama
From €1650EUR$1,850USD£1,431GBP
- Report
- November 2022
Pakistan
From €1650EUR$1,850USD£1,431GBP
- Report
- November 2022
Asia Pacific
From €12929EUR$14,500USD£11,220GBP
- Report
- November 2022
Vietnam
From €1650EUR$1,850USD£1,431GBP
- Report
- November 2022
United States
From €3433EUR$3,850USD£2,979GBP
- Report
- November 2022
United Kingdom
From €3121EUR$3,500USD£2,708GBP
The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings.
The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests.
Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more